D-0659-2016 Class III Terminated
FDA drug recall D-0659-2016 was initiated by Sandoz Inc on Dec 31, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; 9 month stability timepoint The recall status is terminated (terminated Apr 12, 2017). Affected quantity: 277,267 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 17, 2016
- Initiation Date
- Dec 31, 2015
- Termination Date
- Apr 12, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 277,267 bottles
Product description
Candesartan Cilexetil Tablets, 16 mg, a) 30 count (NDC 00781-5938-31) and b) 90 count (NDC 00781-5938-92) bottles, Rx Only, Manufactured by Mylan Laboratories Limited Hyderabad 500 034, India for Sandoz Inc. Princeton, NJ 08540
Reason for recall
Failed Impurities/Degradation Specifications; 9 month stability timepoint
Distribution pattern
Nationwide
Code information
a) 3022288 12/2015 3025988 03/2016 3025989 04/2016 3030459 08/2016 3030460 08/2016 3032087 10/2016 3032088 10/2016 3034506 12/2016 3035952 01/2017 3035953 01/2017 b) 3022287 12/2015 3025990 04/2016 3030458 08/2016 3032086 09/2016 3035954 01/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0659-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026